Contribute Try STAT+ Today

Sue Desmond-Hellmann has some experience when it comes to health care.

She began her career as an oncologist in San Francisco, and later worked in Kampala, Uganda, treating patients with AIDS-related cancer. She later was appointed president of Genentech, before serving as chancellor of the University of California, San Francisco. For the past 5 1/2 years, she has served as CEO of the Bill and Melinda Gates Foundation. At age 62, she will step down from that post at the end of this month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.